Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab

IMPORTANCE: Low sodium levels have been associated with negative outcomes among patients with metastatic renal cell carcinoma (mRCC) receiving therapies other than immune checkpoint inhibitors (ICIs). OBJECTIVE: To investigate the role of natremia in patients with mRCC receiving nivolumab as a secon...

Descripción completa

Detalles Bibliográficos
Autores principales: Catalano, Martina, Rebuzzi, Sara Elena, Maruzzo, Marco, De Giorgi, Ugo, Buti, Sebastiano, Galli, Luca, Fornarini, Giuseppe, Zucali, Paolo Andrea, Procopio, Giuseppe, Chiellino, Silvia, Milella, Michele, Catalano, Fabio, Pipitone, Stefania, Ricotta, Riccardo, Sorarù, Mariella, Mollica, Veronica, Tudini, Marianna, Fratino, Lucia, Prati, Veronica, Caffo, Orazio, Atzori, Francesco, Morelli, Franco, Prati, Giuseppe, Nolè, Franco, Vignani, Francesca, Cavo, Alessia, Di Napoli, Marilena, Malgeri, Andrea, Naglieri, Emanuele, Signori, Alessio, Banna, Giuseppe Luigi, Rescigno, Pasquale, Antonuzzo, Lorenzo, Roviello, Giandomenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682835/
https://www.ncbi.nlm.nih.gov/pubmed/38010650
http://dx.doi.org/10.1001/jamanetworkopen.2023.45185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682835/
https://www.ncbi.nlm.nih.gov/pubmed/38010650
http://dx.doi.org/10.1001/jamanetworkopen.2023.45185

Ejemplares similares